Esperion Therapeutics, Inc. (ESPR)
NASDAQ: ESPR · Real-Time Price · USD
0.9400
+0.0103 (1.11%)
At close: Apr 23, 2025, 4:00 PM
0.9500
+0.0100 (1.06%)
After-hours: Apr 23, 2025, 6:31 PM EDT
Esperion Therapeutics Market Cap
Esperion Therapeutics has a market cap or net worth of $185.98 million as of April 23, 2025. Its market cap has decreased by -68.98% in one year.
Market Cap
185.98M
Enterprise Value
634.25M
1-Year Change
-68.98%
Ranking
Category
Stock Price
$0.94
Market Cap Chart
Since June 26, 2013, Esperion Therapeutics's market cap has decreased from $204.10M to $185.98M, a decrease of -8.88%. That is a compound annual growth rate of -0.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2025 | 184.00M | -57.55% |
| Dec 31, 2024 | 433.50M | 27.50% |
| Dec 29, 2023 | 340.00M | -25.93% |
| Dec 30, 2022 | 459.00M | 215.68% |
| Dec 31, 2021 | 145.40M | -79.94% |
| Dec 31, 2020 | 724.80M | -55.52% |
| Dec 31, 2019 | 1.63B | 32.13% |
| Dec 31, 2018 | 1.23B | -28.50% |
| Dec 29, 2017 | 1.72B | 510.80% |
| Dec 30, 2016 | 282.40M | -43.67% |
| Dec 31, 2015 | 501.30M | -39.08% |
| Dec 31, 2014 | 822.90M | 290.00% |
| Dec 31, 2013 | 211.00M | 3.38% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 743.12B |
| UnitedHealth Group | 388.83B |
| Johnson & Johnson | 380.15B |
| AbbVie | 307.41B |
| Novo Nordisk | 266.18B |
| Abbott Laboratories | 228.46B |
| Novartis AG | 211.63B |
| AstraZeneca | 210.34B |